SEVERANCE PLAN AGREEMENTSeverance Plan Agreement • August 9th, 2023 • European Wax Center, Inc. • Services-personal services
Contract Type FiledAugust 9th, 2023 Company IndustryWHEREAS, the European Wax Center, Inc. (the “Company”) has adopted the European Wax Center, Inc. Change in Control and Severance Plan, effective February 22, 2023 (the “Severance Plan”), pursuant to which Andrea Wasserman (the “Executive”) is entitled to certain severance payments and benefits upon termination of the Executive’s employment by the Company without Cause or by the Executive for Good Reason, as set forth in the Severance Plan and as such terms are defined in the Severance Plan; and
Amended and restated CHANGE IN CONTROL AND EXECUTIVE SEVERANCE PLAN AGREEMENTSeverance Plan Agreement • December 5th, 2022 • Oncocyte Corp • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledDecember 5th, 2022 Company Industry JurisdictionThis Amended and Restated Change in Control and Executive Severance Plan Agreement (the “Agreement”) is entered into by and between Josh Riggs (“you” or “your”) and Oncocyte Corporation (the “Company”). This Agreement has an effective date of December 2, 2022 (the “Effective Date”). The Board has authorized the Company to enter into this Agreement in order for you to become a Covered Employee participant under the Oncocyte Corporation Change in Control and Severance Plan (the “Plan”). This Agreement enumerates the Plan benefits that may be provided to you as a Covered Employee as referenced in Section II of the Plan. All provisions of this Agreement are subject to and governed by the terms of the Plan. In the event of any conflict in terms between the Plan and this Agreement, the terms of the Plan shall prevail and govern.
SEVERANCE PLAN AGREEMENTSeverance Plan Agreement • May 10th, 2023 • European Wax Center, Inc. • Services-personal services
Contract Type FiledMay 10th, 2023 Company IndustryWHEREAS, the European Wax Center, Inc. (the “Company”) has adopted the European Wax Center, Inc. Change in Control and Severance Plan, effective February 22, 2023 (the “Severance Plan”), pursuant to which Stacie Shirley (the “Executive”) is entitled to certain severance payments and benefits upon termination of the Executive’s employment by the Company without Cause or by the Executive for Good Reason, as set forth in the Severance Plan and as such terms are defined in the Severance Plan; and